catecholomethyltransferase comt inhibitor drug inhibits enzyme catecholomethyltransferase enzyme methylates catecholamines dopamine norepinephrine epinephrine also methylates levodopa comt inhibitors indicated treatment parkinsons disease combination levodopa aromatic lamino acid decarboxylase inhibitor eg carbidopa benserazide therapeutic benefit using comt inhibitor based ability prevent methylation levodopa thus increasing bioavailability levodopa comt inhibitors significantly decrease time people parkinsons disease also taking entacapone opicapone peripheral inhibitors unable cross bloodbrain barrier tolcapone able cross bloodbrain tolcapone associated least three fatal cases acute liver failure thus rarely patients taking tolcapone must monitored hepatic failure entacapone opicapone associated drug article relating nervous system stub help wikipedia expanding httpsenwikipediaorgwikicatecholomethyltransferaseinhibitor